Zimmer A M, Holmes R A
Nucl Med (Stuttg). 1975 Jun 30;14(2):192-5.
New chromatographic procedures are needed to accurately determine the radiochemical purity of technetium-99m labeled radiopharmaceuticals. A chromatography system has been developed for technetium-99m diethylenetriaminepentacetic acid, technetium-99m diphosphonate, and technetium-99m pyrophosphate. The technique involves spotting the radiopharmaceuticals on instant thin layer chromatography-silica gel and developing with acetone (solvent from migrates approximately 12 cm from the origin), air drying, and redeveloping the strip in normal saline (solvent front migrates approximately 6 cm from the origin). The procedure is simple to perform, rapid, accurate, and clearly separates technetium-99m pertechnetate, the technetium-99m radiopharmaceutical, and hydrolyzed reduced technetium-99m. It can be applied in most nuclear medicine laboratories and has the potential to predict the quality of radionuclide images obtained.
需要新的色谱程序来准确测定锝-99m标记放射性药物的放射化学纯度。已开发出一种用于锝-99m二乙三胺五乙酸、锝-99m二膦酸盐和锝-99m焦磷酸盐的色谱系统。该技术包括将放射性药物点样在即时薄层色谱硅胶上,用丙酮展开(溶剂前沿从原点迁移约12厘米),空气干燥,然后在生理盐水中重新展开条带(溶剂前沿从原点迁移约6厘米)。该程序操作简单、快速、准确,能清晰分离高锝酸盐-99m、锝-99m放射性药物和水解还原的锝-99m。它可应用于大多数核医学实验室,并有可能预测所获得的放射性核素图像的质量。